News and Opinion from the Pandemic Sciences Institute at the Nuffield Department of Medicine, University of Oxford
Oxford hosts Belgian vaccine experts
28 March 2024
News Vaccines, treatments, diagnostics & trials
Researchers from Oxford Vaccine Group and the Pandemic Sciences Institute welcomed a delegation of vaccine researchers from Belgium to further UK-Belgian collaboration on vaccine development and manufacture.
Speaker line-up announced for the International Pandemic Sciences Conference 2024
27 March 2024
Meet the presenters, panellists and chairs for the International Pandemic Sciences Conference 2024, set to take place on 1–2 July 2024 in Oxford and online.
New Pandemic PACT research programme launched
21 March 2024
Ethics, social science & humanities Research news
The Pandemic Sciences Institute, in collaboration with the global coalition of health research funders GloPID-R and UKCDR, has launched a new research programme including an interactive platform to track and analyse over $7 billion in global pandemic research funding.
Study reveals high number of persistent COVID-19 infections in the general population
21 February 2024
Epidemiology & data Research news
A new study – led by researchers at PSI – has found that a high proportion of SARS-CoV-2 infections in the general population lead to persistent infections lasting a month or more. The findings have been published today in the journal Nature.
Abstract submission deadline extended: International Pandemic Sciences Conference 2024
15 February 2024
The deadline for abstract submissions and bursary applications for the International Pandemic Sciences Conference 2024 – Collaboration Beyond Boundaries has been extended to Monday 26 February 2024.
Students explore 'wicked problem' of pandemics
12 February 2024
Students on the MSc International Health and Tropical Medicine programme discussed pandemics, during a day exploring some of the major challenges in global health, hosted by PSI's Dr Alice Norton.
New teaching collaboration with Brazilian universities
7 February 2024
The University of Oxford has entered into an agreement with three Brazilian universities, to contribute to the delivery of an undergraduate course in ‘Translational Science’, starting in 2024. The course will teach the full journey of a product ‘from bench to bedside’ as part of any science degree to prepare the next generation of researchers for the translation of their laboratory discoveries into patient care and prevention.
FCDO Minister meets with University of Oxford’s vaccine researchers
26 January 2024
Partner news Vaccines, treatments, diagnostics & trials
The University of Oxford this week welcomed the Rt Hon Andrew Mitchell MP, Minister for Development and Africa, to the laboratories and clinics of several of its vaccine development groups.
Registration open for International Pandemic Sciences Conference 2024
25 January 2024
PSI set to host international scientific conference in Oxford and online this July, to foster global research collaboration and prepare world for future pandemics.
Public health vision led by researchers from Oxford and Bangladesh aims to tackle Nipah virus
11 January 2024
In a new paper published in The Lancet Infectious Diseases, researchers based in Bangladesh, Oxford and Geneva call for a comprehensive public health framework to counter Nipah virus and other neglected infectious diseases with pandemic potential.
Vaccine trial for deadly Nipah virus launched
11 January 2024
Nipah virus Research news Vaccines, treatments, diagnostics & trials
Oxford-led UK trial is first step to developing a vaccine against Nipah virus – a devastating disease mostly found in South-East Asia.
New partnership aims to advance vaccine against MERS coronavirus
21 December 2023
Partner news Vaccines, treatments, diagnostics & trials
A partnership between CEPI, Barinthus Biotherapeutics and the University of Oxford aims to fast-track the development of a potential vaccine for the prevention of Middle East Respiratory Syndrome (MERS).
Study reveals that duration of exposure to COVID-19 plays major role in risk of catching the virus
20 December 2023
Epidemiology & data Research news
Using data from 7 million people notified by the NHS COVID-19 contact tracing app, this is the first large-scale study to reveal how duration and proximity of contact with an infected person affects how COVID-19 is spread.
Nipah virus: How a neglected disease raises new ethical questions
18 December 2023
Ethics, social science & humanities Nipah virus Research news
New University of Oxford research brings to light important ethical considerations in Nipah virus outbreak control, its treatment, and research into vaccines.
Funders Roadmap is supporting better clinical trials
14 December 2023
Ethics, social science & humanities Research news
New framework helps funders to support coordinated, effective and equitable clinical trials in response to epidemics and pandemics.
Oxford receives £7.8 million to develop vaccines to fight epidemic and pandemic threats
12 December 2023
Partner news Vaccines, treatments, diagnostics & trials
New funding will support research into the prevention of five dangerous diseases with epidemic and pandemic potential.
Call for applications to establish networks of epidemic and pandemic sciences research excellence across Africa
16 November 2023
PSI has joined forces with the Science for Africa Foundation and the Mastercard Foundation to launch a call for applications to establish innovative networks of research excellence in epidemic and pandemic sciences across Africa.
Oxford welcomes global pandemic experts for focus on 100 Days Mission
2 November 2023
Partner news Vaccines, treatments, diagnostics & trials
Scientific advisors to the International Pandemic Preparedness Secretariat (IPPS) visited the University of Oxford’s vaccine laboratories as part of a two-day meeting of the global coalition.
CEPI and University of Oxford advance vaccine work against potentially deadly Arenaviruses
2 November 2023
Research news Vaccines, treatments, diagnostics & trials
CEPI will provide up to $25 million to the University of Oxford to complete early development of prototype vaccines against the Junín virus, with a new project led by Professor Teresa Lambe.
World-leading RECOVERY trial expands to investigate treatments for influenza
30 October 2023
The RECOVERY trial, the leading global clinical trial of treatments for COVID-19, has expanded to find effective treatments for patients hospitalised with flu.